EFG
LABU icon

Ethos Financial Group’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Ethos Financial Group’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$624K Hold
3,915
– – 0.05% 275
2025
Q4 		$624K Sell
3,915
-4,957
-56% -$681K 0.05% 260
2025
Q3 		$831K Sell
8,872
-183
-2% -$12.9K 0.07% 201
2025
Q2 		$515K Buy
9,055
+2,270
+33% +$120K 0.04% 258
2025
Q1 		$414K Buy
+6,785
New +$578K 0.04% 268

Other funds holding LABU

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
JF
Jump Financial Chicago, Illinois $7.5B AUM 33.9% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
MIG
McGuire Investment Group Wakefield, Rhode Island $885M AUM 47.78% 1-Year Est. Return
Belvedere Trading
Belvedere Trading Chicago, Illinois $84.4B AUM 52.68% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Ethos Financial Group's LABU Position: Q1 2026 in Review

Ethos Financial Group held its Direxion Daily S&P Biotech Bull 3X ETF (LABU) position steady in Q1 2026 at 3,915 shares worth $624K. The position accounts for 0.05% of the portfolio, ranked #275.

Ethos Financial Group first reported a position in LABU in Q1 2025 and has held it in 5 quarters since. The position peaked at $831K in Q3 2025. 33 funds tracked by Wall St. Rank hold LABU as of Q1 2026.

  • Ethos Financial Group held 3,915 shares of Direxion Daily S&P Biotech Bull 3X ETF worth $624K as of Q1 2026.
  • Ethos Financial Group left its Direxion Daily S&P Biotech Bull 3X ETF share count unchanged in Q1 2026.
  • Direxion Daily S&P Biotech Bull 3X ETF made up 0.05% of Ethos Financial Group's portfolio in Q1 2026, its #275 holding.
  • Ethos Financial Group first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q1 2025 and has held it in 5 quarters since.
  • Ethos Financial Group's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $831K in Q3 2025.
  • 33 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q1 2026.

Based on Ethos Financial Group's 13F filing for Q1 2026, filed 5 May 2026.